Ebola Virus Disease: A Review of Its Past and Present

Anesthesia and Analgesia

Volumn 121, Issue 3, 2015, Pages 798-809

  Murray, Michael J ^a  

^a Grand Canyon Anesthesia Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; EBOLA VACCINE; ENFUVIRTIDE; FIBRINOLYTIC AGENT; NUCLEOSIDE ANALOG; SMALL INTERFERING RNA; ZMAPP;

ANTIVIRAL THERAPY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FIBRINOLYTIC THERAPY; HUMAN; INFECTION CONTROL; LETHALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; VIRUS DIAGNOSIS; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; AFRICA; DISEASE OUTBREAKS; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; ISOLATION AND PURIFICATION;

AFRICA; DISEASE OUTBREAKS; EBOLAVIRUS; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84940104261     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000866     Document Type: Review

References (78)

1. World Health Organization EVD in Spain 2014
2. World Health Organization Determining End of an Outbreak 2014
3. Centers for Disease Control Cases of Ebola Diagnosed in the United States 2014
4. WHO Ebola Response Team Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014 371 1481 95
5. World Health Organization EVD: October 31 Update 2014
6. Adams MJ, Lefkowitz EJ, King AM, Carstens EB, Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2014). Arch Virol 2014 159 2831 41
7. Taylor DJ, Leach RW, Bruenn J, Filoviruses are ancient and integrated into mammalian genomes. BMC Evol Biol 2010 10 193
8. Suzuki Y, Gojobori T, The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol 1997 14 800 6
9. Balter M, Emerging diseases. On the trail of Ebola and Marburg viruses. Science 2000 290 923 5
10. Kiley MP, Regnery RL, Johnson KM, Ebola virus: identification of virion structural proteins. J Gen Virol 1980 49 333 41
11. Ebola haemorrhagic fever in Sudan, 1976 Report of a WHO/International Study Team. Bull World Health Organ 1978 56 247 70
12. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978 56 271 93
13. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ, Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 1990 335 502 5
14. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh WJ, Batten B, Sealy TK, Carrillo C, Moran KE, Bracht AJ, Mayr GA, Sirios-Cruz M, Catbagan DP, Lautner EA, Ksiazek TG, White WR, McIntosh MT, Discovery of swine as a host for the Reston ebolavirus. Science 2009 325 204 6
15. Le Guenno B, Formenty P, Formentry P, Wyers M, Gounon P, Walker F, Boesch C, Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995 345 1271 4
16. Towner JS, Sealy TK, Khristova ML, Albariño CG, Conlan S, Reeder SA, Quan PL, Lipkin WI, Downing R, Tappero JW, Okware S, Lutwama J, Bakamutumaho B, Kayiwa J, Comer JA, Rollin PE, Ksiazek TG, Nichol ST, Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008 4 e1000212
17. Walsh PD, Abernethy KA, Bermejo M, Beyers R, De Wachter P, Akou ME, Huijbregts B, Mambounga DI, Toham AK, Kilbourn AM, Lahm SA, Latour S, Maisels F, Mbina C, Mihindou Y, Obiang SN, Effa EN, Starkey MP, Telfer P, Thibault M, Tutin CE, White LJ, Wilkie DS, Catastrophic ape decline in western equatorial Africa. Nature 2003 422 611 4
18. Weingartl HM, Nfon C, Kobinger G, Review of Ebola virus infections in domestic animals. Dev Biol (Basel) 2013 135 211 8
19. Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS, Kansiime E, Kagirita A, Ahimbisibwe S, Katunguka F, Jeffs B, Lutwama JJ, Downing R, Tappero JW, Formenty P, Amman B, Manning C, Towner J, Nichol ST, Rollin PE, Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J Infect Dis 2011 204 Suppl 3 S796 9
20. World Health Organization EVD: Update 2014
21. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez JP, Swanepoel R, Fruit bats as reservoirs of Ebola virus. Nature 2005 438 575 6
22. Hayman DT, Yu M, Crameri G, Wang LF, Suu-Ire R, Wood JL, Cunningham AA, Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerg Infect Dis 2012 18 1207 9
23. Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, Brady OJ, Kraemer MU, Smith DL, Moyes CL, Bhatt S, Gething PW, Horby PW, Bogoch II, Brownstein JS, Mekaru SR, Tatem AJ, Khan K, Hay SI, Mapping the zoonotic niche of Ebola virus disease in Africa. Elife 2014 3 e04395
24. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P, Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 2009 9 723 8
25. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LE, Ksiazek TG, Rollin PE, Zaki SR, Peters CJ, Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 1996 2 321 5
26. Smith DH, Johnson BK, Isaacson M, Swanapoel R, Johnson KM, Killey M, Bagshawe A, Siongok T, Keruga WK, Marburg-virus disease in Kenya. Lancet 1982 1 816 20
27. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A, Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 1999 179 Suppl 1 S48 53
28. Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, Obiang PI, Lepage JP, Bertherat EJ, Benoni DD, Wickings EJ, Amblard JP, Lansoud-Soukate JM, Milleliri JM, Baize S, Georges-Courbot MC, Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infec Dis 1999 179 Suppl 1 S65 75
29. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC, Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014 345 1369 72
30. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Akena D, Alasfoor D, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Al Kahbouri MJ, Alla F, Allen PJ, AlMazroa MA, Alsharif U, Alvarez E, Alvis-Guzmán N, Amankwaa AA, Amare AT, Amini H, Ammar W, Antonio CA, Anwari P, Arnlöv J, Arsenijevic VS, Artaman A, Asad MM, Asghar RJ, Assadi R, Atkins LS, Badawi A, Balakrishnan K, Basu A, Basu S, Beardsley J, Bedi N, Bekele T, Bell ML, Bernabe E, Beyene TJ, Bhutta Z, Bin Abdulhak A, Blore JD, Basara BB, Bose D, Breitborde N, Cárdenas R, Castañeda-Orjuela CA, Castro RE, Catalá-López F, Cavlin A, Chang JC, Che X, Christophi CA, Chugh SS, Cirillo M, Colquhoun SM, Cooper LT, Cooper C, da Costa Leite I, Dandona L, Dandona R, Davis A, Dayama A, Degenhardt L, De Leo D, del Pozo-Cruz B, Deribe K, Dessalegn M, deVeber GA, Dharmaratne SD, Dilmen U, Ding EL, Dorrington RE, Driscoll TR, Ermakov SP, Esteghamati A, Faraon EJ, Farzadfar F, Felicio MM, Fereshtehnejad SM, de Lima GM, Forouzanfar MH, França EB, Gaffikin L, Gambashidze K, Gankpé FG, Garcia AC, Geleijnse JM, Gibney KB, Giroud M, Glaser EL, Goginashvili K, Gona P, González-Castell D, Goto A, Gouda HN, Gugnani HC, Gupta R, Gupta R, Hafezi-Nejad N, Hamadeh RR, Hammami M, Hankey GJ, Harb HL, Havmoeller R, Hay SI, Pi IB, Hoek HW, Hosgood HD, Hoy DG, Husseini A, Idrisov BT, Innos K, Inoue M, Jacobsen KH, Jahangir E, Jee SH, Jensen PN, Jha V, Jiang G, Jonas JB, Juel K, Kabagambe EK, Kan H, Karam NE, Karch A, Karema CK, Kaul A, Kawakami N, Kazanjan K, Kazi DS, Kemp AH, Kengne AP, Kereselidze M, Khader YS, Khalifa SE, Khan EA, Khang YH, Knibbs L, Kokubo Y, Kosen S, Defo BK, Kulkarni C, Kulkarni VS, Kumar GA, Kumar K, Kumar RB, Kwan G, Lai T, Lalloo R, Lam H, Lansingh VC, Larsson A, Lee JT, Leigh J, Leinsalu M, Leung R, Li X, Li Y, Li Y, Liang J, Liang X, Lim SS, Lin HH, Lipshultz SE, Liu S, Liu Y, Lloyd BK, London SJ, Lotufo PA, Ma J, Ma S, Machado VM, Mainoo NK, Majdan M, Mapoma CC, Marcenes W, Marzan MB, Mason-Jones AJ, Mehndiratta MM, Mejia-Rodriguez F, Memish ZA, Mendoza W, Miller TR, Mills EJ, Mokdad AH, Mola GL, Monasta L, de la Cruz Monis J, Hernandez JC, Moore AR, Moradi-Lakeh M, Mori R, Mueller UO, Mukaigawara M, Naheed A, Naidoo KS, Nand D, Nangia V, Nash D, Nejjari C, Nelson RG, Neupane SP, Newton CR, Ng M, Nieuwenhuijsen MJ, Nisar MI, Nolte S, Norheim OF, Nyakarahuka L, Oh IH, Ohkubo T, Olusanya BO, Omer SB, Opio JN, Orisakwe OE, Pandian JD, Papachristou C, Park JH, Caicedo AJ, Patten SB, Paul VK, Pavlin BI, Pearce N, Pereira DM, Pesudovs K, Petzold M, Poenaru D, Polanczyk GV, Polinder S, Pope D, Pourmalek F, Qato D, Quistberg DA, Rafay A, Rahimi K, Rahimi-Movaghar V, ur Rahman S, Raju M, Rana SM, Refaat A, Ronfani L, Roy N, Pimienta TG, Sahraian MA, Salomon JA, Sampson U, Santos IS, Sawhney M, Sayinzoga F, Schneider IJ, Schumacher A, Schwebel DC, Seedat S, Sepanlou SG, Servan-Mori EE, Shakh-Nazarova M, Sheikhbahaei S, Shibuya K, Shin HH, Shiue I, Sigfusdottir ID, Silberberg DH, Silva AP, Singh JA, Skirbekk V, Sliwa K, Soshnikov SS, Sposato LA, Sreeramareddy CT, Stroumpoulis K, Sturua L, Sykes BL, Tabb KM, Talongwa RT, Tan F, Teixeira CM, Tenkorang EY, Terkawi AS, Thorne-Lyman AL, Tirschwell DL, Towbin JA, Tran BX, Tsilimbaris M, Uchendu US, Ukwaja KN, Undurraga EA, Uzun SB, Vallely AJ, van Gool CH, Vasankari TJ, Vavilala MS, Venketasubramanian N, Villalpando S, Violante FS, Vlassov VV, Vos T, Waller S, Wang H, Wang L, Wang X, Wang Y, Weichenthal S, Weiderpass E, Weintraub RG, Westerman R, Wilkinson JD, Woldeyohannes SM, Wong JQ, Wordofa MA, Xu G, Yang YC, Yano Y, Yentur GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Yu C, Jin KY, El Sayed Zaki M, Zhao Y, Zheng Y, Zhou M, Zhu J, Zou XN, Lopez AD, Naghavi M, Murray CJ, Lozano R, Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014 384 980 1004
31. Rahi M, Human development report 2010: Changes in parameters and perspectives. Indian J Public Health 2011 55 272 5
32. Ebola: protection of health workers on the front line. Lancet 2014 384 470
33. Wiwanitkit V, Ebola, fear and preparedness. Epidemiol Health 2014 36 e2014015
34. Nishiura H, Chowell G, Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill 2014 19 pii: 20907
35. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE, Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007 196 Suppl 2 S142 7
36. Johnson E, Jaax N, White J, Jahrling P, Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995 76 227 36
37. Reed DS, Lackemeyer MG, Garza NL, Sullivan LJ, Nichols DK, Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect 2011 13 930 6
38. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C, Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 346 1669 71
39. Alimonti J, Leung A, Jones S, Gren J, Qiu X, Fernando L, Balcewich B, Wong G, Ströher U, Grolla A, Strong J, Kobinger G, Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep 2014 4 5824
40. Roels TH, Bloom AS, Buffington J, Muhungu GL, Mac Kenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, Ksiazek TG, Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 179 Suppl 1 S92 7
41. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR, Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 2015 235 153 74
42. Leffel EK, Reed DS, Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2004 2 186 91
43. Sagripanti JL, Lytle CD, Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Arch Virol 2011 156 489 94
44. Sagripanti JL, Rom AM, Holland LE, Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch Virol 2010 155 2035 9
45. Missair A, Marino MJ, Vu CN, Gutierrez J, Missair A, Osman B, Gebhard RE, Anesthetic implications of ebola patient management: a review of the literature and policies. Anesth Analg 2015 121 810 21
46. Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB, Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002 8 503 7
47. Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ, Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003 424 681 4
48. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y, A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 1997 94 14764 9
49. Niknafs N, Kim D, Kim R, Diekhans M, Ryan M, Stenson PD, Cooper DN, Karchin R, MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures. Hum Genet 2013 132 1235 43
50. Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y, Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000 278 20 6
51. Alvarez CP, Lasala F, Carrillo J, Muñiz O, Corbí AL, Delgado R, C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002 76 6841 4
52. Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DI, Neild GH, Barrett AJ, Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 1983 2 1055 8
53. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobasa D, Feldmann H, Irimura T, Kawaoka Y, Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 2004 78 2943 7
54. Baskerville A, Fisher-Hoch SP, Neild GH, Dowsett AB, Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol 1985 147 199 209
55. Zaki SR, Goldsmith CS, Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999 235 97 116
56. Lin G, Simmons G, Pöhlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW, Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003 77 1337 46
57. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pöhlmann S, DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003 305 115 23
58. Geisbert TW, Jahrling PB, Differentiation of filoviruses by electron microscopy. Virus Res 1995 39 129 50
59. Agopian A, Castano S, Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models. Biochim Biophys Acta 2014 1838 117 26
60. Trunschke M, Conrad D, Enterlein S, Olejnik J, Brauburger K, Mühlberger E, The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Virology 2013 441 135 45
61. Lu J, Qu Y, Liu Y, Jambusaria R, Han Z, Ruthel G, Freedman BD, Harty RN, Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J Virol 2013 87 7777 80
62. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B, Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 2003 170 2797 801
63. Baumann H, Gauldie J, The acute phase response. Immunol Today 1994 15 74 80
64. Goldsmith CS, Miller SE, Modern uses of electron microscopy for detection of viruses. Clin Microbiol Rev 2009 22 552 63
65. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E, Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002 128 163 8
66. Hutchinson KL, Rollin PE, Cytokine and chemokine expression in humans infected with Sudan ebolavirus. J Infect Dis 2007 196 Suppl 2 S357 63
67. Geisbert TW, Hensley LE, Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 2004 6 1 24
68. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE, Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003 188 1618 29
69. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R, Nichol ST, Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004 78 4330 41
70. Pattyn S, van der Groen G, Jacob W, Piot P, Courteille G, Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet 1977 1 573 4
71. World Health Organization Target Product Profile for a Rapid Simple Test for Zaïre ebolavirus 2014
72. Gubler DJ, Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998 11 480 96
73. Basler CF, A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein. Expert Rev Anti Infect Ther 2013 11 475 8
74. World Health Organization Convalescent Therapy 2014
75. Qiu X, Kobinger GP, Antibody therapy for Ebola: is the tide turning around? Hum Vaccin Immunother 2014 10 964 7
76. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014 514 47 53
77. Butler D, Ebola drug trials set to begin amid crisis. Nature 2014 513 13 4
78. Zapata JC, Cox D, Salvato MS, The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis 2014 8 e2858